Bob Harrington

Robert A. Harrington, MD The Bob Harrington Show

Dr. Robert A. Harrington is an interventional cardiologist and Professor of Medicine and Chairman of the Department of Medicine at Stanford University. He was previously the Richard Sean Stack, MD, Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures; studying the mechanism of disease of the acute coronary syndromes; understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes; building local, national, and international collaborations for the efficient conduct of innovative clinical research; and trying to better understand and improve upon the methodology of clinical trials.

When not focusing on medicine, Dr. Harrington dreams of being a radio commentator for the Boston Red Sox.

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.


Latest Articles by Bob Harrington

  • Hot Topics in Cardiology: Tech, Twitter, and the Hypertension Guidelines   Drs Harrington and Gibson discuss burning issues in medicine, including artificial intelligence, social media, wearable tech, and the new hypertension guidelines.
  • 7 Cardiology Trials to Look for in 2018   Trials on PCSK9 inhibitors, antiplatelets, anticoagulants, and even catheter ablation of atrial fibrillation are among Drs Harrington and Gibson's picks for what to look for in 2018.
  • Public Reporting as Public Shaming, and Potential Solutions   A recent viewpoint by Dr Bhatt against public reporting of PCI outcomes garnered a lot of support in the cardiology community and beyond. Dr Harrington asks how it can be done better.
  • The Top Cardiology Trials of 2017 in Review   In this annual tradition, Drs Harrington and Gibson discuss their picks for the top cardiology trials of the year, covering PCSK9 inhibitors, anti-inflammatory and anthithrombotic drugs, and PCI.
  • The Complexities Behind High Prescription Prices   Drs Harrington and Kesselheim discuss the varied reasons why prescription drugs are so pricey and whether policies can interrupt this alarming trend.
  • Life After the FDA: Mining Data and Reducing Disparities   Dr Califf talks about his new role at Verily and how data mining and data sharing could reduce disparities in care and improve patient outcomes.
  • Dr Rob Califf on His Short-Lived Tenure as FDA Commissioner   From being critiqued by Bernie Sanders to the controversial Duchenne drug approval decision, Dr Califf recounts his experiences as FDA commissioner.
  • The VA System: An Integrated Healthcare Example for All   The Veterans Health Administration is the largest integrated healthcare system in the US with a common EHR. Dr Harrington learns the advantages for cardiology practice and research.
  • Making Cardiology Family-Friendly Helps Men and Women   Why are only 13% of cardiologists women? Drs Harrington and Duvernoy discuss results from the recent ACC lifestyle survey and strategies for making cardiology 'a more human place.'
  • Cardiology 2016: The Politics of Medicine   In part 2 of their yearly review of cardiology news, Drs Harrington and Gibson focus on the politics and policy of medical practice --what will happen to the ACA under President Trump?